2024-520142-32-00招募中1 期
A study investigating the safety, absorption, and elimination of NT 0150, a new compound that may potentially be used in the treatment of brain disorders, like Alzheimer’s disease and Parkinson’s disease.
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 53
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Nick Clarke
Scientific
Nodthera Limited
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A study investigating the safety, absorption, and elimination of radioactively labeled RO7269162, a new compound that may potentially be used in the treatment of Alzheimer’s disease.2024-513234-37-00F. Hoffmann-La Roche AG10
招募中
1 期
A study investigating the safety, absorption, and elimination of NNC0705-0001, a new compound that could potentially be used in the treatment of cardiometabolic diseases caused by inflammation.2024-519478-38-00Novo Nordisk A/S116
招募中
1 期
A study investigating the safety, absorption, and elimination of RO7795081, a
new compound that may potentially be used in the treatment of type 2 diabetes and weight control2025-522766-78-00F. Hoffmann-La Roche AG16
已完成
不适用
A study for evaluating the safety of the intake of a test food for healthy adults.JPRN-UMIN000032670TTC Co.,Ltd20
已完成
Unknown
A study for evaluating the safety of the intake of a test food.Healthy adultJPRN-UMIN000045361EP Mediate Co., Ltd.48